Evidence mapPaperPMID 41008370Full record

ReviewBrain sciences2025

Autism Spectrum Disorder: What Do We Know and Where Do We Go?

Gerry Leisman, Robert Melillo

Abstract readReview
In one paragraph

Review in Brain sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gerry LeismanMovement and Cognition Laboratory, Department of Physical Therapy, University of Haifa, Haifa 3498838, Israel.ORCID 0000-0002-9975-7331
Robert MelilloMovement and Cognition Laboratory, Department of Physical Therapy, University of Haifa, Haifa 3498838, Israel.ORCID 0000-0003-4405-0192

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is a complex neurodevelopmental condition that manifests in early childhood and persists throughout an individual's life. Characterized by a range of symptoms affecting social interaction, communication, and behavior, ASD presents a spectrum of varying degrees of severity and presentation. Recent research emphasizes the importance of understanding the diverse manifestations of ASD across different populations. Core features include social communication differences and restricted and repetitive behaviors (RRBs), often linked to co-occurring conditions such as anxiety and ADHD. The study of ASD has evolved significantly, highlighting the need for individualized approaches to diagnosis and intervention. This paper explores current knowledge on ASD, examining the latest research findings and discussing future directions for improving the lives of those affected by the disorder. The purpose is to present a map of the field and an evidence-strength framing of what is known and unknown, and where the evidence is equivocal. Key areas of focus include behavioral, psychological, genetic, metabolic, immunological, and neurological features, as well as developmental and maturational factors. The aim is to provide a comprehensive overview of what is known, what remains unclear, and where future research should be directed.

Indexed as

autism spectrum disorder (ASD)brain connectivitydevelopmental trajectoriesgenetic and metabolic mechanismsimmunological dysregulationneurodevelopment

Identifiers

PMID41008370
PMCPMC12468522

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.